STOCK MARKET BSE NSE

JIPMER Intellectual Property Right Policy Released

JIPMER director Dr S C Parija released the policy and the first copy was received by Dr Vishnu Bhat, Dean, Research.

Published: 10th April 2016 05:18 PM  |   Last Updated: 10th April 2016 05:18 PM   |  A+A-

PUDUCHERRY: As part of the efforts to boost research, JIPMER has come out with an Intellectual Property Right (IPR) policy, formed by JIPMER Patent Cell to guide the faculty and students to apply for various innovations and patents.

After releasing the IPR policy document, Director of JIPMER, Dr S C Parija, said  JIPMER, an institution of national importance is aiming to get at least three to five patents by the end of this year to mark a beginning.

JIPMER director Dr S C Parija released the policy and the first copy was received by Dr Vishnu Bhat, Dean, Research.

He said though considerable research is going on in various fields by the different departments of JIPMER, the institution could not get any patent so far. He said 45 Post Graduates and nearly 200 faculty members are engaged in various research projects and over 400 to 500 research papers were being published per year in internationally renowned journals.

The JIPMER director said the JIPMER patent Cell (JPC) and IPR Policy will help and encourage all JIPMER employees and students in the their efforts tom identify the innovative component of the research and seek patent protection before publication, to commercially exploit all new knowledge generated .

 The Cell will provide legal and other support needed for IP protection, technology transfer, licensing and commercialization of products, he added.

The JIPMER director said the initiatives will ultimately reach the poor patients, who approach the institution of national importance for quality health care treatment.

As example, he said, the HIV and Typhoid kits developed for treatment of the diseases will cost more and the country has spend more on foreign exchange. Our researchers can develop the kits indigenous and it will reduce the cost of the treatment considerably. Ultimately this will help the poor patients and the country itself, he said.

The JPC (in charge), Dr Ravi Kumar Chittoria said: “We want the patient (clinical) and laboratory researches done by various departments should receive its due recognition by getting the patents.”

The JIPMER organized a programme for the researchers on Sunday with experts Dr M Kantha Babu, Anna University, Pridarshini Naveenkumar and Preethi Narayanan addressing the participants.

Asked about the Karaikal campus of JPMER, the academic session will begin this year with the admission process in July itself.

 Answering a query, he said a high level inquiry conducted on sexual harassment committed by the staff of private security agency and the responsible persons were removed from duty in the premises.

Stay up to date on all the latest Tamil Nadu news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp